{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Confiance : Questions médicales les plus fréquentes",
"headline": "Confiance : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Confiance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-22",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Confiance"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Relations interpersonnelles",
"url": "https://questionsmedicales.fr/mesh/D007398",
"about": {
"@type": "MedicalCondition",
"name": "Relations interpersonnelles",
"code": {
"@type": "MedicalCode",
"code": "D007398",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.829.401"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Confiance",
"alternateName": "Trust",
"code": {
"@type": "MedicalCode",
"code": "D035502",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peter Fonagy",
"url": "https://questionsmedicales.fr/author/Peter%20Fonagy",
"affiliation": {
"@type": "Organization",
"name": "Anna Freud National Centre for Children and Families, London, United Kingdom."
}
},
{
"@type": "Person",
"name": "H Holden Thorp",
"url": "https://questionsmedicales.fr/author/H%20Holden%20Thorp",
"affiliation": {
"@type": "Organization",
"name": "H. Holden Thorp Editor-in-Chief, Science journals."
}
},
{
"@type": "Person",
"name": "Angelo Cangelosi",
"url": "https://questionsmedicales.fr/author/Angelo%20Cangelosi",
"affiliation": {
"@type": "Organization",
"name": "1 Cognitive Robotics Laboratory, The University of Manchester , Manchester, M13 9PL , UK."
}
},
{
"@type": "Person",
"name": "Jonathan H Marks",
"url": "https://questionsmedicales.fr/author/Jonathan%20H%20Marks",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "An-Sofie Vanhouche",
"url": "https://questionsmedicales.fr/author/An-Sofie%20Vanhouche",
"affiliation": {
"@type": "Organization",
"name": "Postdoctoral Researcher at the Crime and Society Research Group of the Vrije Universiteit Brussel, Belgium. Electronic address: An-Sofie.Vanhouche@vub.be."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37511475",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411715"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36894035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.02.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36855007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12350-023-03202-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimal age to stop prostate cancer screening and early detection.",
"datePublished": "2023-08-19",
"url": "https://questionsmedicales.fr/article/37598870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcpo.2023.100443"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36121650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijc.34298"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Comportement et mécanismes comportementaux",
"item": "https://questionsmedicales.fr/mesh/D001520"
},
{
"@type": "ListItem",
"position": 3,
"name": "Relations interpersonnelles",
"item": "https://questionsmedicales.fr/mesh/D007398"
},
{
"@type": "ListItem",
"position": 4,
"name": "Confiance",
"item": "https://questionsmedicales.fr/mesh/D035502"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Confiance - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Confiance",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Confiance",
"description": "Comment évaluer la confiance d'un patient ?\nQuels facteurs influencent la confiance des patients ?\nLa confiance affecte-t-elle l'adhésion au traitement ?\nComment mesurer la confiance dans les soins de santé ?\nQuel rôle joue la transparence dans la confiance ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Confiance",
"description": "Quels symptômes indiquent une perte de confiance ?\nComment la méfiance se manifeste-t-elle chez un patient ?\nQuels signes montrent une confiance élevée ?\nLa confiance peut-elle affecter le bien-être psychologique ?\nQuels symptômes psychologiques sont liés à la méfiance ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Confiance",
"description": "Comment prévenir la méfiance envers les médecins ?\nQuel rôle joue l'éducation des patients dans la confiance ?\nComment les politiques de santé influencent-elles la confiance ?\nLes campagnes de sensibilisation peuvent-elles aider ?\nComment la technologie influence-t-elle la confiance ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Confiance",
"description": "Comment améliorer la confiance dans le traitement ?\nLes traitements alternatifs affectent-ils la confiance ?\nComment la confiance influence-t-elle les résultats des traitements ?\nLes effets secondaires affectent-ils la confiance ?\nComment les médecins peuvent-ils renforcer la confiance ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Confiance",
"description": "Quelles complications peuvent résulter d'une faible confiance ?\nComment la méfiance affecte-t-elle les soins préventifs ?\nLes complications psychologiques sont-elles liées à la confiance ?\nComment la confiance influence-t-elle les résultats cliniques ?\nQuelles sont les conséquences d'une mauvaise communication ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Confiance",
"description": "Quels facteurs augmentent le risque de méfiance ?\nL'âge influence-t-il la confiance des patients ?\nLes antécédents médicaux affectent-ils la confiance ?\nLe niveau d'éducation influence-t-il la confiance ?\nLes différences culturelles affectent-elles la confiance ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la confiance d'un patient ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires et des entretiens peuvent mesurer la confiance du patient envers le médecin."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent la confiance des patients ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'expérience antérieure, la communication et la réputation du médecin influencent la confiance."
}
},
{
"@type": "Question",
"name": "La confiance affecte-t-elle l'adhésion au traitement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une confiance élevée augmente l'adhésion aux traitements prescrits par le médecin."
}
},
{
"@type": "Question",
"name": "Comment mesurer la confiance dans les soins de santé ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échelles de mesure et des enquêtes peuvent évaluer la confiance dans les soins de santé."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la transparence dans la confiance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La transparence des informations médicales renforce la confiance entre le patient et le médecin."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une perte de confiance ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété, la méfiance et la réticence à poser des questions peuvent signaler une perte de confiance."
}
},
{
"@type": "Question",
"name": "Comment la méfiance se manifeste-t-elle chez un patient ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La méfiance peut se manifester par des doutes sur les diagnostics ou les traitements proposés."
}
},
{
"@type": "Question",
"name": "Quels signes montrent une confiance élevée ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un patient qui pose des questions et suit les recommandations montre une confiance élevée."
}
},
{
"@type": "Question",
"name": "La confiance peut-elle affecter le bien-être psychologique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une faible confiance peut entraîner du stress et affecter le bien-être psychologique."
}
},
{
"@type": "Question",
"name": "Quels symptômes psychologiques sont liés à la méfiance ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La méfiance peut entraîner des symptômes comme la dépression et l'anxiété chez les patients."
}
},
{
"@type": "Question",
"name": "Comment prévenir la méfiance envers les médecins ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La formation continue des médecins et la transparence des soins peuvent prévenir la méfiance."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation des patients dans la confiance ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation des patients sur leur santé renforce leur confiance envers les professionnels de santé."
}
},
{
"@type": "Question",
"name": "Comment les politiques de santé influencent-elles la confiance ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des politiques de santé transparentes et éthiques renforcent la confiance du public dans le système de santé."
}
},
{
"@type": "Question",
"name": "Les campagnes de sensibilisation peuvent-elles aider ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les campagnes de sensibilisation sur la santé renforcent la confiance des patients dans les soins."
}
},
{
"@type": "Question",
"name": "Comment la technologie influence-t-elle la confiance ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La technologie peut renforcer la confiance par l'accès à l'information et la communication améliorée."
}
},
{
"@type": "Question",
"name": "Comment améliorer la confiance dans le traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une communication claire et des explications détaillées peuvent améliorer la confiance dans le traitement."
}
},
{
"@type": "Question",
"name": "Les traitements alternatifs affectent-ils la confiance ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation de traitements alternatifs peut diminuer la confiance dans les soins conventionnels."
}
},
{
"@type": "Question",
"name": "Comment la confiance influence-t-elle les résultats des traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une confiance élevée peut améliorer l'efficacité des traitements et la satisfaction des patients."
}
},
{
"@type": "Question",
"name": "Les effets secondaires affectent-ils la confiance ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les effets secondaires peuvent diminuer la confiance des patients dans le traitement prescrit."
}
},
{
"@type": "Question",
"name": "Comment les médecins peuvent-ils renforcer la confiance ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médecins peuvent renforcer la confiance par l'écoute active et la validation des préoccupations des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une faible confiance ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une faible confiance peut entraîner une mauvaise adhésion aux traitements et des complications de santé."
}
},
{
"@type": "Question",
"name": "Comment la méfiance affecte-t-elle les soins préventifs ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La méfiance peut réduire l'utilisation des soins préventifs, augmentant le risque de maladies."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles liées à la confiance ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une faible confiance peut entraîner des complications psychologiques comme l'anxiété et la dépression."
}
},
{
"@type": "Question",
"name": "Comment la confiance influence-t-elle les résultats cliniques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une confiance élevée est associée à de meilleurs résultats cliniques et à une satisfaction accrue."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une mauvaise communication ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise communication peut entraîner des malentendus et diminuer la confiance entre patient et médecin."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de méfiance ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des expériences négatives antérieures et un manque de communication augmentent le risque de méfiance."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la confiance des patients ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients plus âgés peuvent avoir des niveaux de confiance différents en fonction de leurs expériences."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux affectent-ils la confiance ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de soins insatisfaisants peuvent diminuer la confiance dans les soins futurs."
}
},
{
"@type": "Question",
"name": "Le niveau d'éducation influence-t-il la confiance ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un niveau d'éducation plus élevé est souvent associé à une meilleure compréhension et confiance."
}
},
{
"@type": "Question",
"name": "Les différences culturelles affectent-elles la confiance ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les différences culturelles peuvent influencer la perception de la confiance dans les soins de santé."
}
}
]
}
]
}
The central objective of the metamorphosis of discovery science into biomedical applications is to serve the purpose of patients and curtail the global disease burden. The journey from the discovery o...
Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv...
The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro...
In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo...
EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....
Cancer therapy-induced cardiotoxicity is an emerging clinical and healthcare issue. Myocardial dysfunction and heart failure are mostly responsible for increased cardiovascular mortality in cancer dis...
Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can...
We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer...
Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the...
Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...
Colorectal cancer (CRC) develops mainly from colorectal advanced adenomas (AA), which are considered precancerous lesions. Novel early diagnostic biomarkers are urgently needed to distinguish CRC and ...
The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can...
This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ...
In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst...
Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...
Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o...
In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me...
This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv...
Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...
Clinical diagnostics rely heavily on the detection and quantification of cancer biomarkers. The rapid detection of cancer-specific biomarkers is of great importance in the early diagnosis of cancers a...
A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. ...
Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir...
This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ...
Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings....
NCT05541601....